{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T02:49:48Z","timestamp":1788922188804,"version":"build-2803163510"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2025,4,11]],"date-time":"2025-04-11T00:00:00Z","timestamp":1744329600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2025,4,11]],"date-time":"2025-04-11T00:00:00Z","timestamp":1744329600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/100008368","name":"Gigtforeningen","doi-asserted-by":"publisher","award":["A6158"],"award-info":[{"award-number":["A6158"]}],"id":[{"id":"10.13039\/100008368","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003035","name":"Aase og Ejnar Danielsens Fond","doi-asserted-by":"publisher","award":["21-10-0037"],"award-info":[{"award-number":["21-10-0037"]}],"id":[{"id":"10.13039\/501100003035","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004196","name":"Odense Universitetshospital","doi-asserted-by":"publisher","award":["A3650"],"award-info":[{"award-number":["A3650"]}],"id":[{"id":"10.13039\/501100004196","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Odense University Hospital"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["CNS Drugs"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1007\/s40263-025-01183-7","type":"journal-article","created":{"date-parts":[[2025,4,11]],"date-time":"2025-04-11T07:00:41Z","timestamp":1744354841000},"page":"685-692","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Effect of Naltrexone on Spinal and Supraspinal Pain Mechanisms and Functional Capacity in Women with Fibromyalgia: Exploratory Outcomes from the Randomized Placebo-Controlled FINAL Trial"],"prefix":"10.1007","volume":"39","clinical-trial-number":[{"clinical-trial-number":"nct0427877","registry":"10.18810\/clinical-trials-gov"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3106-2461","authenticated-orcid":false,"given":"Karin Due","family":"Bruun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6600-0631","authenticated-orcid":false,"given":"Robin","family":"Christensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0792-505X","authenticated-orcid":false,"given":"Kirstine","family":"Amris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7759-5642","authenticated-orcid":false,"given":"Morten Rune","family":"Blichfeldt-Eckhardt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Bye-M\u00f8ller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1091-2962","authenticated-orcid":false,"given":"Marius","family":"Henriksen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9105-3882","authenticated-orcid":false,"given":"Tine","family":"Alkjaer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3188-449X","authenticated-orcid":false,"given":"Palle","family":"Toft","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4106-6930","authenticated-orcid":false,"given":"Anders","family":"Holsgaard-Larsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7707-9947","authenticated-orcid":false,"given":"Henrik Bjarke","family":"Vaegter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,11]]},"reference":[{"issue":"1","key":"1183_CR1","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2023-003904","volume":"10","author":"K Amris","year":"2024","unstructured":"Amris K, Ibsen R, Duhn PH, Olsen J, Lolk K, Kjellberg J, Kristensen LE. Health inequities and societal costs for patients with fibromyalgia and their spouses: a Danish cohort study. RMD Open. 2024;10(1): e003904.","journal-title":"RMD Open"},{"issue":"11","key":"1183_CR2","doi-asserted-by":"publisher","first-page":"2470","DOI":"10.1016\/j.pain.2011.05.027","volume":"152","author":"K Amris","year":"2011","unstructured":"Amris K, Waehrens EE, Jespersen A, Bliddal H, Danneskiold-Samsoe B. Observation-based assessment of functional ability in patients with chronic widespread pain: a cross-sectional study. Pain. 2011;152(11):2470\u20136.","journal-title":"Pain"},{"issue":"4","key":"1183_CR3","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1111\/j.1600-0838.2011.01401.x","volume":"23","author":"VA Aparicio","year":"2013","unstructured":"Aparicio VA, Carbonell-Baeza A, Ruiz JR, Aranda P, Tercedor P, Delgado-Fernandez M, Ortega FB. Fitness testing as a discriminative tool for the diagnosis and monitoring of fibromyalgia. Scand J Med Sci Sports. 2013;23(4):415\u201323.","journal-title":"Scand J Med Sci Sports"},{"issue":"6","key":"1183_CR4","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1136\/annrheumdis-2012-202340","volume":"72","author":"E Bandak","year":"2013","unstructured":"Bandak E, Amris K, Bliddal H, Danneskiold-Samsoe B, Henriksen M. Muscle fatigue in fibromyalgia is in the brain, not in the muscles: a case-control study of perceived versus objective muscle fatigue. Ann Rheum Dis. 2013;72(6):963\u20136.","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"1183_CR5","volume":"8","author":"KJL Bested","year":"2023","unstructured":"Bested KJL, Andresen T, Tarp G, Skovbjerg L, Johansen TSD, Schmedes AV, Storgaard I, Madsen J, Werner MU, Bendiksen A. Low-dose naltrexone for treatment of pain in patients with fibromyalgia: a randomized, double-blind, placebo-controlled, crossover study. Pain Rep. 2023;8(4): e1088.","journal-title":"Pain Rep."},{"issue":"3","key":"1183_CR6","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.mehy.2008.06.048","volume":"72","author":"N Brown","year":"2009","unstructured":"Brown N, Panksepp J. Low-dose naltrexone for disease prevention and quality of life. Med Hypotheses. 2009;72(3):333\u20137.","journal-title":"Med Hypotheses"},{"issue":"1","key":"1183_CR7","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1186\/s13063-021-05776-7","volume":"22","author":"KD Bruun","year":"2021","unstructured":"Bruun KD, Amris K, Vaegter HB, Blichfeldt-Eckhardt MR, Holsgaard-Larsen A, Christensen R, Toft P. Low-dose naltrexone for the treatment of fibromyalgia: protocol for a double-blind, randomized, placebo-controlled trial. Trials. 2021;22(1):804.","journal-title":"Trials"},{"issue":"2","key":"1183_CR8","first-page":"157","volume":"36","author":"A Carbonell-Baeza","year":"2015","unstructured":"Carbonell-Baeza A, Alvarez-Gallardo IC, Segura-Jimenez V, Castro-Pinero J, Ruiz JR, Delgado-Fernandez M, Aparicio VA. Reliability and feasibility of physical fitness tests in female fibromyalgia patients. Int J Sports Med. 2015;36(2):157\u201362.","journal-title":"Int J Sports Med"},{"key":"1183_CR9","doi-asserted-by":"publisher","first-page":"243","DOI":"10.2340\/17453674.2023.11656","volume":"94","author":"R Christensen","year":"2023","unstructured":"Christensen R, Ranstam J, Overgaard S, Wagner P. Guidelines for a structured manuscript: statistical methods and reporting in biomedical research journals. Acta Orthop. 2023;94:243\u20139.","journal-title":"Acta Orthop"},{"issue":"15","key":"1183_CR10","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1001\/jama.2014.3266","volume":"311","author":"DJ Clauw","year":"2014","unstructured":"Clauw DJ. Fibromyalgia: a clinical review. JAMA. 2014;311(15):1547\u201355.","journal-title":"JAMA"},{"issue":"4","key":"1183_CR11","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.3390\/biomedicines11041087","volume":"11","author":"CN Driver","year":"2023","unstructured":"Driver CN, D\u2019Souza RS. Efficacy of low-dose naltrexone and predictors of treatment success or discontinuation in fibromyalgia and other chronic pain conditions: a fourteen-year, enterprise-wide retrospective analysis. Biomedicines. 2023;11(4):1087.","journal-title":"Biomedicines"},{"issue":"1","key":"1183_CR12","doi-asserted-by":"publisher","first-page":"e31","DOI":"10.1016\/S2665-9913(23)00278-3","volume":"6","author":"K Due Bruun","year":"2024","unstructured":"Due Bruun K, Christensen R, Amris K, Vaegter HB, Blichfeldt-Eckhardt MR, Bye-Moller L, Holsgaard-Larsen A, Toft P. Naltrexone 6 mg once daily versus placebo in women with fibromyalgia: a randomised, double-blind, placebo-controlled trial. Lancet Rheumatol. 2024;6(1):e31\u20139.","journal-title":"Lancet Rheumatol"},{"key":"1183_CR13","doi-asserted-by":"crossref","unstructured":"Gil-Ugidos A, Rubal-Otero L, Gonzalez-Villar A, Carrillo-De-la-Pena MT. Conditioned pain modulation (CPM) paradigms: reliability and relationship with individual characteristics. Pain Manag Nurs. 2024.","DOI":"10.1016\/j.pmn.2024.12.001"},{"issue":"11","key":"1183_CR14","doi-asserted-by":"publisher","first-page":"2193","DOI":"10.1097\/j.pain.0000000000000294","volume":"156","author":"T Graven-Nielsen","year":"2015","unstructured":"Graven-Nielsen T, Vaegter HB, Finocchietti S, Handberg G, Arendt-Nielsen L. Assessment of musculoskeletal pain sensitivity and temporal summation by cuff pressure algometry: a reliability study. Pain. 2015;156(11):2193\u2013202.","journal-title":"Pain"},{"issue":"9","key":"1183_CR15","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.1007\/s00296-017-3725-2","volume":"37","author":"F Heidari","year":"2017","unstructured":"Heidari F, Afshari M, Moosazadeh M. Prevalence of fibromyalgia in general population and patients, a systematic review and meta-analysis. Rheumatol Int. 2017;37(9):1527\u201339.","journal-title":"Rheumatol Int"},{"issue":"1","key":"1183_CR16","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.pain.2012.10.008","volume":"154","author":"G Hirschfeld","year":"2013","unstructured":"Hirschfeld G, Zernikow B. Variability of \u201coptimal\u201d cut points for mild, moderate, and severe pain: neglected problems when comparing groups. Pain. 2013;154(1):154\u20139.","journal-title":"Pain"},{"issue":"4","key":"1183_CR17","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1016\/j.rbr.2016.10.004","volume":"57","author":"AP Marques","year":"2017","unstructured":"Marques AP, Santo A, Berssaneti AA, Matsutani LA, Yuan SLK. Prevalence of fibromyalgia: literature review update. Rev Bras Reumatol Engl Ed. 2017;57(4):356\u201363.","journal-title":"Rev Bras Reumatol Engl Ed"},{"issue":"11","key":"1183_CR18","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.1111\/pme.12220","volume":"14","author":"MO Martel","year":"2013","unstructured":"Martel MO, Wasan AD, Edwards RR. Sex differences in the stability of conditioned pain modulation (CPM) among patients with chronic pain. Pain Med. 2013;14(11):1757\u201368.","journal-title":"Pain Med"},{"issue":"13","key":"1183_CR19","doi-asserted-by":"publisher","first-page":"2344","DOI":"10.3390\/ijerph16132344","volume":"16","author":"JP Martin-Martinez","year":"2019","unstructured":"Martin-Martinez JP, Collado-Mateo D, Dominguez-Munoz FJ, Villafaina S, Gusi N, Perez-Gomez J. Reliability of the 30 s chair stand test in women with fibromyalgia. Int J Environ Res Public Health. 2019;16(13):2344.","journal-title":"Int J Environ Res Public Health"},{"issue":"12","key":"1183_CR20","doi-asserted-by":"publisher","first-page":"1990","DOI":"10.1111\/imj.15430","volume":"51","author":"V Mezhov","year":"2021","unstructured":"Mezhov V, Guymer E, Littlejohn G. Central sensitivity and fibromyalgia. Intern Med J. 2021;51(12):1990\u20138.","journal-title":"Intern Med J"},{"issue":"3","key":"1183_CR21","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1016\/j.berh.2007.03.007","volume":"21","author":"LA Nielsen","year":"2007","unstructured":"Nielsen LA, Henriksson KG. Pathophysiological mechanisms in chronic musculoskeletal pain (fibromyalgia): the role of central and peripheral sensitization and pain disinhibition. Best Pract Res Clin Rheumatol. 2007;21(3):465\u201380.","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"8","key":"1183_CR22","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1016\/j.jpain.2018.01.010","volume":"19","author":"AT O'Brien","year":"2018","unstructured":"O\u2019Brien AT, Deitos A, Trinanes Pego Y, Fregni F, Carrillo-de-la-Pena MT. Defective endogenous pain modulation in fibromyalgia: a meta-analysis of temporal summation and conditioned pain modulation paradigms. J Pain. 2018;19(8):819\u201336.","journal-title":"J Pain"},{"issue":"9","key":"1183_CR23","doi-asserted-by":"publisher","first-page":"2097","DOI":"10.3390\/biomedicines12092097","volume":"12","author":"K Pacheco-Barrios","year":"2024","unstructured":"Pacheco-Barrios K, Filardi RM, Gonzalez-Gonzalez LF, Park N, Petrus FQ, Navarro-Flores A, Di-Bonaventura S, Alves LG, Queiroz F, Fregni F. The link between endogenous pain modulation changes and clinical improvement in fibromyalgia syndrome: a meta-regression analysis. Biomedicines. 2024;12(9):2097.","journal-title":"Biomedicines"},{"issue":"2","key":"1183_CR24","doi-asserted-by":"publisher","first-page":"16","DOI":"10.3390\/biomedicines5020016","volume":"5","author":"L Parkitny","year":"2017","unstructured":"Parkitny L, Younger J. Reduced pro-inflammatory cytokines after eight weeks of low-dose naltrexone for fibromyalgia. Biomedicines. 2017;5(2):16.","journal-title":"Biomedicines"},{"issue":"5","key":"1183_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2023.e15638","volume":"9","author":"S Partridge","year":"2023","unstructured":"Partridge S, Quadt L, Bolton M, Eccles J, Thompson C, Colasanti A, Bremner S, Jones CI, Bruun KD, Van Marwijk H. A systematic literature review on the clinical efficacy of low dose naltrexone and its effect on putative pathophysiological mechanisms among patients diagnosed with fibromyalgia. Heliyon. 2023;9(5): e15638.","journal-title":"Heliyon"},{"issue":"3","key":"1183_CR26","doi-asserted-by":"publisher","DOI":"10.1002\/ejp.4741","volume":"29","author":"KK Petersen","year":"2024","unstructured":"Petersen KK, O\u2019Neill S, Blichfeldt-Eckhardt MR, Nim C, Arendt-Nielsen L, Vaegter HB. Pain profiles and variability in temporal summation of pain and conditioned pain modulation in pain-free individuals and patients with low back pain, osteoarthritis, and fibromyalgia. Eur J Pain. 2024;29(3): e4741.","journal-title":"Eur J Pain"},{"issue":"8","key":"1183_CR27","doi-asserted-by":"publisher","first-page":"3891","DOI":"10.3390\/ijms22083891","volume":"22","author":"R Siracusa","year":"2021","unstructured":"Siracusa R, Paola RD, Cuzzocrea S, Impellizzeri D. Fibromyalgia: pathogenesis, mechanisms, diagnosis and treatment options update. Int J Mol Sci. 2021;22(8):3891.","journal-title":"Int J Mol Sci"},{"issue":"7","key":"1183_CR28","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1097\/j.pain.0000000000000543","volume":"157","author":"HB Vaegter","year":"2016","unstructured":"Vaegter HB, Graven-Nielsen T. Pain modulatory phenotypes differentiate subgroups with different clinical and experimental pain sensitivity. Pain. 2016;157(7):1480\u20138.","journal-title":"Pain"},{"issue":"7321","key":"1183_CR29","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1136\/bmj.323.7321.1123","volume":"323","author":"AJ Vickers","year":"2001","unstructured":"Vickers AJ, Altman DG. Statistics notes: analysing controlled trials with baseline and follow up measurements. BMJ. 2001;323(7321):1123\u20134.","journal-title":"BMJ"},{"issue":"3","key":"1183_CR30","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.semarthrit.2016.08.012","volume":"46","author":"F Wolfe","year":"2016","unstructured":"Wolfe F, Clauw DJ, Fitzcharles MA, Goldenberg DL, Hauser W, Katz RL, Mease PJ, Russell AS, Russell IJ, Walitt B. 2016 revisions to the 2010\/2011 fibromyalgia diagnostic criteria. Semin Arthritis Rheum. 2016;46(3):319\u201329.","journal-title":"Semin Arthritis Rheum"},{"issue":"2","key":"1183_CR31","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1002\/art.1780330203","volume":"33","author":"F Wolfe","year":"1990","unstructured":"Wolfe F, Smythe HA, Yunus MB, Bennett RM, Bombardier C, Goldenberg DL, Tugwell P, Campbell SM, Abeles M, Clark P. The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis Rheum-Us. 1990;33(2):160\u201372.","journal-title":"Arthritis Rheum-Us"},{"issue":"9","key":"1183_CR32","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0203755","volume":"13","author":"F Wolfe","year":"2018","unstructured":"Wolfe F, Walitt B, Perrot S, Rasker JJ, Hauser W. Fibromyalgia diagnosis and biased assessment: sex, prevalence and bias. PLoS ONE. 2018;13(9): e0203755.","journal-title":"PLoS ONE"},{"issue":"4","key":"1183_CR33","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1007\/s10067-014-2517-2","volume":"33","author":"J Younger","year":"2014","unstructured":"Younger J, Parkitny L, McLain D. The use of low-dose naltrexone (LDN) as a novel anti-inflammatory treatment for chronic pain. Clin Rheumatol. 2014;33(4):451\u20139.","journal-title":"Clin Rheumatol"}],"container-title":["CNS Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40263-025-01183-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40263-025-01183-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40263-025-01183-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,13]],"date-time":"2025-06-13T09:46:48Z","timestamp":1749808008000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40263-025-01183-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,11]]},"references-count":33,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["1183"],"URL":"https:\/\/doi.org\/10.1007\/s40263-025-01183-7","relation":{},"ISSN":["1172-7047","1179-1934"],"issn-type":[{"value":"1172-7047","type":"print"},{"value":"1179-1934","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,11]]},"assertion":[{"value":"26 March 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 April 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Open access funding provided by Odense University Hospital. The Danish Rheumatism Association (A6158), Odense University Hospital\u2019s PhD fund (A3650), and Danielsen\u2019s fund (21-10-0037) supported the study. The Parker Institute, Bispebjerg, and Frederiksberg Hospital are supported by a core grant from the Oak Foundation (OFIL-24-074). The funders had no role in the study\u2019s conception and design, the data interpretation, or the writing of the report.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"No actual or potential conflicts of interest exist for any of the authors (K.D.B., R.C., K.A., M.R.B.-E., L.B.-M., M.H., T.A., P.T., A.H.-L., and H.V.).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study received approval from The Ethical Committee of Southern Denmark (S-20190133), the Danish Health and Medicines Authority (19\/26406) and was reported to The Danish Data Protection Agency. All procedures in the study adhered to the principles of the Helsinki Declaration.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Written informed consent was obtained from all participants before their inclusion in the study.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}},{"value":"All authors contributed to the study\u2019s conception and design. Study nurse Eva McGehee performed data collection, and Henrik Bjarke Vaegter performed the analysis. Karin Due Bruun wrote the first draft of the manuscript, and all others contributed to revising it. All authors read and approved the final version of the manuscript.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Author contribution"}},{"value":"De-identified data can be acquired, preceded by a signed data access agreement form.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Data availability"}},{"value":"Not applicable.","order":9,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code availability"}}]}}